Literature DB >> 2826017

Cell cycle specificity of tumor necrosis factor and its receptor.

N Watanabe1, Y Niitsu, N Yamauchi, H Neda, H Sone, M Maeda, I Urushizaki.   

Abstract

Phase specificity in the TNF cytotoxic effect and the number of TNF binding receptors was investigated using L-M cells incubated synchronously from the S phase. TNF cytotoxicity was observed to occur at various levels during the cell cycle, with peak effect in the G2-M phase. Analysis with 125I-labeled TNF to determine the number of receptors binding TNF in the various cell phases shewed a phase specificity with the maximum number occurring in the G2-M phase, similar to the peak in cytotoxicity. The results suggest the existence of a cell cycle specificity in the cytotoxicity of TNF which is apparently related to changes in the number of receptors capable of binding TNF.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2826017     DOI: 10.1016/0309-1651(87)90160-3

Source DB:  PubMed          Journal:  Cell Biol Int Rep        ISSN: 0309-1651


  3 in total

1.  Lack of cell-cycle-specific effects of recombinant tumor necrosis factor in vivo.

Authors:  M Jäckel; P Köpf-Maier; R Tausch-Treml
Journal:  Cancer Immunol Immunother       Date:  1994-11       Impact factor: 6.968

2.  Inhibition of transcription factor nuclear factor-kappaB by a mutant inhibitor-kappaBalpha attenuates resistance of human head and neck squamous cell carcinoma to TNF-alpha caspase-mediated cell death.

Authors:  D C Duffey; C V Crowl-Bancroft; Z Chen; F G Ondrey; M Nejad-Sattari; G Dong; C Van Waes
Journal:  Br J Cancer       Date:  2000-11       Impact factor: 7.640

3.  Mechanism of synergistic cytotoxic effect between tumor necrosis factor and hyperthermia.

Authors:  N Yamauchi; N Watanabe; M Maeda; T Okamoto; H Sasaki; N Tsuji; Y Tsuji; H Umeno; S Akiyama; Y Niitsu
Journal:  Jpn J Cancer Res       Date:  1992-05
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.